In a groundbreaking development, the Global Medical Telepresence Robots Industry is poised for exponential growth, currently valued at US$ 61.1 million in 2022 and projected to surge to an impressive US$ 459.1 million by 2032. This meteoric rise reflects a remarkable compound annual growth rate (CAGR) of 22.5% throu.
The worldwide Addison’s Disease Testing market is poised to achieve a total of US$ 249.8 million by the year 2023, with an anticipated Compound Annual Growth Rate (CAGR) of 3.4%. Looking ahead to 2033, this market is projected to reach a substantial valuation of US$ 349.7 million. The increasing adoption of emergenc.